The CB(1)/CB(2) receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro

Cancer (Kaposi's Sarcoma)

Key Findings

WIN55,212-2 reduced viability of human Kaposi’s sarcoma cells in vitro.

Information and Links


Link: The CB(1)/CB(2) receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro

Year: 2009

DOI: 10.1016/j.ejphar.2009.06.004


Ratings

(How Ratings Work)

Cancer (Kaposi's Sarcoma) — 1


Possibility of efficacy for cannabis in treatment of Cancer (Kaposi's Sarcoma) according to the results found in this study.

Drugs Used

Synthetic cannabinoid WIN55,212-2